These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 416147)

  • 1. The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland.
    Sivonen A; Renkonen OV; Weckström P; Koskenvuo K; Raunio V; Mäkelä PH
    J Infect Dis; 1978 Mar; 137(3):238-44. PubMed ID: 416147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin and minocycline in meningococcal disease.
    Beaty HN
    Rev Infect Dis; 1983; 5 Suppl 3():S451-8. PubMed ID: 6415780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community.
    Nicolle LE; Postl B; Kotelewetz E; Remillard F; Bourgault AM; Albritton W; Harding GK; Ronald A
    J Infect Dis; 1982 Jan; 145(1):103-9. PubMed ID: 6798128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemoprophylaxis of cerebrospinal meningitis using rifampin in a military population.
    Chapalain JC; Guibourdenche M; Perrier-Gros-Claude JD; Bartoli M; Riou JY
    Pathol Biol (Paris); 1992 Mar; 40(3):230-3. PubMed ID: 1608666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline for prophylaxis of infection with Neisseria meningitidis: high rate of side effects in recipients.
    Drew TM; Altman R; Black K; Goldfield M
    J Infect Dis; 1976 Feb; 133(2):194-8. PubMed ID: 812929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline in the chemoprophylaxis of meningococcal disease.
    Guttler RB; Beaty HN
    Antimicrob Agents Chemother; 1972 May; 1(5):397-402. PubMed ID: 4670480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974.
    JAMA; 1976 Jan; 235(3):261-5. PubMed ID: 811822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis for meningococcal disease.
    Artenstein MS
    JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of group-A meningococcal vaccine in army recruits in Finland.
    Mäkelä PH; Käyhty H; Weckström P; Sivonen A; Renkonen OV
    Lancet; 1975 Nov; 2(7941):883-6. PubMed ID: 53370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for preventing meningococcal infections.
    Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2011 Aug; (8):CD004785. PubMed ID: 21833949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of Rifampin on the nasopharyngeal carriage of Neisseria meningitidis. A preliminary report.
    Beam WE; Newberg NR; Devine LF
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):316-20. PubMed ID: 4996195
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.
    Schwartz B; Al-Tobaiqi A; Al-Ruwais A; Fontaine RE; A'ashi J; Hightower AW; Broome CV; Music SI
    Lancet; 1988 Jun; 1(8597):1239-42. PubMed ID: 2897515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibioprophylaxis of Meningococcus group B meningitis. Must we implicate the use of the spiramycin].
    Garre M; L'Emeillat M; Garo B; Boles JM
    Pathol Biol (Paris); 1987 May; 35(5):624-5. PubMed ID: 3302871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains.
    Weidmer CE; Dunkel TB; Pettyjohn FS; Smith CD; Leibovitz A
    J Infect Dis; 1971 Aug; 124(2):172-8. PubMed ID: 5001453
    [No Abstract]   [Full Text] [Related]  

  • 16. Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers.
    Devine LF; Hannah JM; Hagerman CR; Rhode SL; Peckinpaugh RO
    Mil Med; 1973 Jan; 138(1):20-4. PubMed ID: 4630051
    [No Abstract]   [Full Text] [Related]  

  • 17. The carrier state: Neisseria meningitidis.
    Broome CV
    J Antimicrob Chemother; 1986 Jul; 18 Suppl A():25-34. PubMed ID: 3091563
    [No Abstract]   [Full Text] [Related]  

  • 18. Meningococcal disease and its control.
    Riley HD
    South Med J; 1973 Jan; 66(1):107-14. PubMed ID: 4630520
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of a rifampicin-resistant meningococcal infection in a teenager.
    Delaune D; Andriamanantena D; Mérens A; Viant E; Aoun O; Ceppa F; Taha MK; Rapp C
    Infection; 2013 Jun; 41(3):705-8. PubMed ID: 23408002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meningococcus profilaxis (author's transl)].
    Pérez Trallero E; Pérez-Yarza E; Ruíz Benito C; Muñóz Baroja I
    Med Clin (Barc); 1979 Nov; 73(9):367-70. PubMed ID: 119117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.